A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies

Abstract Views: 2026
PDF: 1052
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In 1972, Sharp et al described the mixed connective tissue disease; such a description corresponded to an apparently distinct rheumatic disease syndrome associated to U1RNP, which is an extractable nuclear antigen or ENA (1). After this clever description, different overlap syndromes that did not meet the EMTC criteria were described. Conceptually Alarcón-Segovia coined the term of “shared autoimmunity”, which was defined by the presence of two or more data compatible with autoimmune disease; such category of disease describes signs or symptoms of certain autoimmune connective diseases, for instance Rupus corresponds to lupus erythematosus associated...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Gutiérrez-Ramos, R., González-Díaz, V., Pacheco-Tovar, M., López-Luna, A., Avalos-Díaz, E., & Herrera-Esparza, R. (2008). A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies. Reumatismo, 60(4), 296–300. https://doi.org/10.4081/reumatismo.2008.296